DMD and Duchenne muscular dystrophy: Therefore, although unsupervised untargeted metabolomics did not provide a complete understanding of the changes in specific metabolic traits as a stand-alone method, it strongly indicated that aberrant metabolism is an integral part of the phenotypic consequences of dystrophin mutations in DMD.